Gender-specific survival after surgical resection for early stage non-small cell lung cancer.

about

Gender-specific survival after surgical resection for early stage non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q39185876

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Gender-specific survival after ...... ge non-small cell lung cancer.

@en

Gender-specific survival after ...... ge non-small cell lung cancer.

@nl

type

Item

label

Gender-specific survival after ...... ge non-small cell lung cancer.

@en

Gender-specific survival after ...... ge non-small cell lung cancer.

@nl

prefLabel

Gender-specific survival after ...... ge non-small cell lung cancer.

@en

Gender-specific survival after ...... ge non-small cell lung cancer.

@nl

P1476

Gender-specific survival after ...... ge non-small cell lung cancer.

@en

P2093

Anders Bugge

http://www.w3.org/2001/XMLSchema#string

Cathrine Brunborg

http://www.w3.org/2001/XMLSchema#string

May Brit Lund

http://www.w3.org/2001/XMLSchema#string

P2860

Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis

Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).

Diagnostic surgical pathology in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.

Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan.

Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival.

Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer.

P304

448-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2016.1253862

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Johny Kongerud

Steinar Solberg

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27846762

http://www.w3.org/2001/XMLSchema#string